Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of LONGEVERON INC
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
0
0
0
No Price
01.05.2026 21:58
Current Prices from LONGEVERON INC
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
LGVN
USD
01.05.2026 21:58
0,88 USD
0,03 USD
+3,48 %
IEX
LGVN
USD
01.05.2026 19:58
0,85 USD
-0,0001 USD
-0,01 %
Share Float & Liquidity
Free Float82,79 %
Shares Float19,3 M
Shares Outstanding23,31 M
Company Profile for LONGEVERON INC Share
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.
